Citius Oncology, Inc. (CTOR)

NASDAQ • Currency in USD

$1.89

+$0.02

+1.07%

Last Update: 11 Sept 2025, 20:00

$148.12M

Market Cap

-6.80

P/E Ratio (TTM)

—

Forward Dividend Yield

$0.55 - $6.19

52 Week Range

CTOR Stock Price Chart

Explore Citius Oncology, Inc. interactive price chart. Choose custom timeframes to analyze CTOR price movements and trends.

CTOR Company Profile

Discover essential business fundamentals and corporate details for Citius Oncology, Inc. (CTOR) to support your stock research and investment decisions.

Sector

Healthcare

Industry

Drug Manufacturers - General

IPO Date

—

Employees

—

Website

CEO

Leonard L. Mazur

Description

Citius Oncology, Inc. focuses on the development of novel targeted oncology therapies. It also engages in the development of LYMPHIR, an orphan indication for the treatment of adults with relapsed or refractory cutaneous T-cell lymphoma. The company is headquartered in New York, New York. Citius Oncology, Inc. operates as a subsidiary of Citius Pharmaceuticals, Inc.

CTOR Financial Timeline

Browse a chronological timeline of Citius Oncology, Inc. corporate events including earnings releases, dividend announcements, and stock splits.

Earnings released on 12 Aug 2025

EPS came in at -$0.08 surpassing the estimated -$0.15 by +46.67%.

Earnings released on 14 May 2025

EPS came in at -$0.11 falling short of the estimated -$0.09 by -22.22%.

Earnings released on 14 Feb 2025

EPS came in at -$0.09 falling short of the estimated -$0.06 by -50.00%.

Earnings released on 27 Dec 2024

EPS came in at -$0.07 surpassing the estimated -$0.08 by +10.33%.

Earnings released on 31 Mar 2024

EPS came in at $0.01 .

Earnings released on 31 Dec 2023

EPS came in at -$0.05 .

Earnings released on 30 Sept 2023

EPS came in at $0.00 .

Earnings released on 30 Jun 2023

EPS came in at $0.07 .

Earnings released on 31 Mar 2023

EPS came in at $0.07 .

Earnings released on 31 Dec 2022

EPS came in at $0.04 .

Earnings released on 30 Sept 2022

EPS came in at -$0.00 .

Earnings released on 30 Jun 2022

EPS came in at -$0.00 .

Earnings released on 30 Apr 2021

EPS came in at -$0.00 .

CTOR Stock Performance

Access detailed CTOR performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.